Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Opthea.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Mesoblast raise signals potential comeback for biotechs
Experts
ScoPo’s Powerplays: Taps on again with ASX health stocks in BIG capital raises
News
Rise and Shine: Everything you need to know before the ASX Opens
Health & Biotech
Here are the Top 10 crucial trials coming up for ASX biotechs in 2022
News
Trading Places: BGH ups Virtus stake to above 50pc as battle for fertility company escalates
Health & Biotech
Check Up: Is biotech a good investment in a higher rate cycle? Turns out theory is just a theory
Health & Biotech
ASX Health Stocks: Opthea presents data at renowned conference; Osprey slashes workforce
News
Market Highlights and 5 ASX Small Caps to watch on Friday
Health & Biotech
ASX Health Stocks: Opthea presents data at global conference; CardieX to progress Philip Morris sponsored study
Health & Biotech
ASX Health Stocks: Opthea and Alterity to present at world renowned biotech conference
Health & Biotech
Check Up: Rhythm plans TGA submission and pig tissue MOU fails to impress
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
ASX Health Stocks: Truscreen jumps 38% on business update, flagging strong growth in China
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
ASX Health Stocks: Pharmaxis progresses to Phase 2 study on bone marrow cancer
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
News